{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:39:28Z","timestamp":1784763568086,"version":"3.55.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T00:00:00Z","timestamp":1695772800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T00:00:00Z","timestamp":1695772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2019 R1A2C1091089"],"award-info":[{"award-number":["NRF-2019 R1A2C1091089"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The purpose of this study was to identify the effect of antihypertensive medication on risks of open-angle glaucoma (OAG) among patients diagnosed with hypertension (HTN). A total of 5,195 patients, who were diagnosed with HTN between January 1, 2006 and December 31, 2015, and subsequently diagnosed with OAG, were selected for analysis. For each OAG patient, 5 non-glaucomatous, hypertensive controls were matched (n\u2009=\u200925,975) in hypertension diagnosis date, residential area, insurance type and economic status. Antihypertensive medications were stratified into 5 types: angiotensin converting enzyme inhibitor (ACEi), angiotensin receptor blockers (ARB), calcium channel blockers (CCB), \u03b2-blockers and diuretics. Relative risks were calculated. After adjusting for age, sex, body mass index, lifestyle, comorbidities, blood pressure (BP), follow-up duration, and use of other types of antihypertensive drugs, ARB and CCB were found to slightly increase OAG risks (RR 1.1087 (95% CI 1.0293\u20131.1942); 1.0694 (1.0077\u20131.1349), respectively). Combinations of ARB with diuretics (1.0893 (1.0349\u20131.1466)) and CCB (1.0548 (1.0122\u20131.0991)) also increased OAG risks. The risks for OAG were found to increase by antihypertensive medication use, but the effects appeared to be small. Further studies are necessary to identify the associations of increased BP, medication and therapeutic effect with OAG.<\/jats:p>","DOI":"10.1038\/s41598-023-43420-3","type":"journal-article","created":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T11:02:24Z","timestamp":1695812544000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Effect of antihypertensive medications on the risk of open-angle glaucoma"],"prefix":"10.1038","volume":"13","author":[{"given":"Jihei Sara","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Ryeong","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyoung Won","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Yeop","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wungrak","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan Yun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,27]]},"reference":[{"key":"43420_CR1","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.2014.3192","volume":"311","author":"RN Weinreb","year":"2014","unstructured":"Weinreb, R. N., Aung, T. & Medeiros, F. A. The pathophysiology and treatment of glaucoma: A review. JAMA 311, 1901\u20131911. https:\/\/doi.org\/10.1001\/jama.2014.3192 (2014).","journal-title":"JAMA"},{"key":"43420_CR2","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/S0140-6736(99)04240-3","volume":"354","author":"AL Coleman","year":"1999","unstructured":"Coleman, A. L. Glaucoma. Lancet 354, 1803\u20131810. https:\/\/doi.org\/10.1016\/S0140-6736(99)04240-3 (1999).","journal-title":"Lancet"},{"key":"43420_CR3","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","volume":"120","author":"A Heijl","year":"2002","unstructured":"Heijl, A. et al. Reduction of intraocular pressure and glaucoma progression: Results from the Early Manifest Glaucoma Trial. Arch. Ophthalmol. 120, 1268\u20131279. https:\/\/doi.org\/10.1001\/archopht.120.10.1268 (2002).","journal-title":"Arch. Ophthalmol."},{"key":"43420_CR4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1167\/iovs.63.3.28","volume":"63","author":"JS Lee","year":"2022","unstructured":"Lee, J. S., Bae, H. W., Park, S., Kim, C. Y. & Lee, S. Y. Systemic arterial stiffness is associated with structural progression in early open-angle glaucoma. Invest. Ophthalmol. Vis. Sci. 63, 28. https:\/\/doi.org\/10.1167\/iovs.63.3.28 (2022).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"43420_CR5","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3129\/i08-061","volume":"43","author":"S Deokule","year":"2008","unstructured":"Deokule, S. & Weinreb, R. N. Relationships among systemic blood pressure, intraocular pressure, and open-angle glaucoma. Can. J. Ophthalmol. 43, 302\u2013307. https:\/\/doi.org\/10.3129\/i08-061 (2008).","journal-title":"Can. J. Ophthalmol."},{"key":"43420_CR6","doi-asserted-by":"publisher","first-page":"e108226","DOI":"10.1371\/journal.pone.0108226","volume":"9","author":"HW Bae","year":"2014","unstructured":"Bae, H. W. et al. Systemic hypertension as a risk factor for open-angle glaucoma: A meta-analysis of population-based studies. PLoS One 9, e108226. https:\/\/doi.org\/10.1371\/journal.pone.0108226 (2014).","journal-title":"PLoS One"},{"key":"43420_CR7","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ophtha.2021.08.021","volume":"129","author":"AA Jammal","year":"2022","unstructured":"Jammal, A. A. et al. Blood pressure and glaucomatous progression in a large clinical population. Ophthalmology 129, 161\u2013170. https:\/\/doi.org\/10.1016\/j.ophtha.2021.08.021 (2022).","journal-title":"Ophthalmology"},{"key":"43420_CR8","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1097\/IJG.0b013e31806540a1","volume":"16","author":"MV Boland","year":"2007","unstructured":"Boland, M. V. & Quigley, H. A. Risk factors and open-angle glaucoma: Classification and application. J. Glaucoma 16, 406\u2013418. https:\/\/doi.org\/10.1097\/IJG.0b013e31806540a1 (2007).","journal-title":"J. Glaucoma"},{"key":"43420_CR9","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1097\/IJG.0b013e31824d1e12","volume":"22","author":"A Harris","year":"2013","unstructured":"Harris, A. et al. Association of the optic disc structure with the use of antihypertensive medications: The thessaloniki eye study. J. Glaucoma 22, 526\u2013531. https:\/\/doi.org\/10.1097\/IJG.0b013e31824d1e12 (2013).","journal-title":"J. Glaucoma"},{"key":"43420_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/IJG.0000000000001964","volume":"31","author":"RO Funk","year":"2022","unstructured":"Funk, R. O., Hodge, D. O., Kohli, D. & Roddy, G. W. Multiple systemic vascular risk factors are associated with low-tension glaucoma. J. Glaucoma 31, 15\u201322. https:\/\/doi.org\/10.1097\/IJG.0000000000001964 (2022).","journal-title":"J. Glaucoma"},{"key":"43420_CR11","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.ophtha.2018.01.007","volume":"125","author":"W Zheng","year":"2018","unstructured":"Zheng, W. et al. Systemic medication associations with presumed advanced or uncontrolled primary open-angle glaucoma. Ophthalmology 125, 984\u2013993. https:\/\/doi.org\/10.1016\/j.ophtha.2018.01.007 (2018).","journal-title":"Ophthalmology"},{"key":"43420_CR12","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1002\/cpt.1490","volume":"106","author":"SV Wang","year":"2019","unstructured":"Wang, S. V. et al. Using healthcare databases to refine understanding of exploratory associations between drugs and progression of open-angle glaucoma. Clin. Pharmacol. Ther. 106, 874\u2013883. https:\/\/doi.org\/10.1002\/cpt.1490 (2019).","journal-title":"Clin. Pharmacol. Ther."},{"key":"43420_CR13","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1001\/archopht.120.7.954","volume":"120","author":"MC Leske","year":"2002","unstructured":"Leske, M. C., Wu, S. Y., Nemesure, B. & Hennis, A. Incident open-angle glaucoma and blood pressure. Arch. Ophthalmol. 120, 954\u2013959. https:\/\/doi.org\/10.1001\/archopht.120.7.954 (2002).","journal-title":"Arch. Ophthalmol."},{"key":"43420_CR14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ophtha.2007.03.017","volume":"115","author":"MC Leske","year":"2008","unstructured":"Leske, M. C. et al. Risk factors for incident open-angle glaucoma: The Barbados Eye Studies. Ophthalmology 115, 85\u201393. https:\/\/doi.org\/10.1016\/j.ophtha.2007.03.017 (2008).","journal-title":"Ophthalmology"},{"key":"43420_CR15","doi-asserted-by":"publisher","first-page":"3399","DOI":"10.1167\/iovs.09-4867","volume":"51","author":"Y Zheng","year":"2010","unstructured":"Zheng, Y. et al. Distribution of ocular perfusion pressure and its relationship with open-angle glaucoma: The singapore malay eye study. Invest. Ophthalmol. Vis. Sci. 51, 3399\u20133404. https:\/\/doi.org\/10.1167\/iovs.09-4867 (2010).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"43420_CR16","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1001\/archopht.125.6.805","volume":"125","author":"CA Hulsman","year":"2007","unstructured":"Hulsman, C. A., Vingerling, J. R., Hofman, A., Witteman, J. C. & de Jong, P. T. Blood pressure, arterial stiffness, and open-angle glaucoma: The Rotterdam study. Arch. Ophthalmol. 125, 805\u2013812. https:\/\/doi.org\/10.1001\/archopht.125.6.805 (2007).","journal-title":"Arch. Ophthalmol."},{"key":"43420_CR17","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ajo.2006.02.055","volume":"142","author":"F Topouzis","year":"2006","unstructured":"Topouzis, F. et al. Association of blood pressure status with the optic disk structure in non-glaucoma subjects: The Thessaloniki eye study. Am. J. Ophthalmol. 142, 60\u201367. https:\/\/doi.org\/10.1016\/j.ajo.2006.02.055 (2006).","journal-title":"Am. J. Ophthalmol."},{"key":"43420_CR18","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1016\/j.ophtha.2007.03.047","volume":"114","author":"RP Muskens","year":"2007","unstructured":"Muskens, R. P. et al. Systemic antihypertensive medication and incident open-angle glaucoma. Ophthalmology 114, 2221\u20132226. https:\/\/doi.org\/10.1016\/j.ophtha.2007.03.047 (2007).","journal-title":"Ophthalmology"},{"key":"43420_CR19","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1136\/bjo.2004.053397","volume":"89","author":"MJ Langman","year":"2005","unstructured":"Langman, M. J., Lancashire, R. J., Cheng, K. K. & Stewart, P. M. Systemic hypertension and glaucoma: Mechanisms in common and co-occurrence. Br. J. Ophthalmol. 89, 960\u2013963. https:\/\/doi.org\/10.1136\/bjo.2004.053397 (2005).","journal-title":"Br. J. Ophthalmol."},{"key":"43420_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2023.03.014","author":"G Leung","year":"2023","unstructured":"Leung, G., Grant, A., Garas, A. N., Li, G. & Freeman, E. E. A systematic review and meta-analysis of systemic antihypertensive medications with intraocular pressure and glaucoma. Am. J. Ophthalmol. https:\/\/doi.org\/10.1016\/j.ajo.2023.03.014 (2023).","journal-title":"Am. J. Ophthalmol."},{"key":"43420_CR21","doi-asserted-by":"publisher","first-page":"115774","DOI":"10.1016\/j.envres.2023.115774","volume":"227","author":"N Duan","year":"2023","unstructured":"Duan, N., Cui, K., Zhu, C. & Jin, S. Study on phase evolution and promoting the pozzolanic activity of electrolytic manganese residue during calcination. Environ. Res. 227, 115774. https:\/\/doi.org\/10.1016\/j.envres.2023.115774 (2023).","journal-title":"Environ. Res."},{"key":"43420_CR22","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ajo.2007.04.040","volume":"144","author":"S Miglior","year":"2007","unstructured":"Miglior, S. et al. Intercurrent factors associated with the development of open-angle glaucoma in the European glaucoma prevention study. Am. J. Ophthalmol. 144, 266\u2013275. https:\/\/doi.org\/10.1016\/j.ajo.2007.04.040 (2007).","journal-title":"Am. J. Ophthalmol."},{"key":"43420_CR23","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.ophtha.2020.07.051","volume":"128","author":"RS Chong","year":"2021","unstructured":"Chong, R. S. et al. Association of antihypertensive medication with retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness. Ophthalmology 128, 393\u2013400. https:\/\/doi.org\/10.1016\/j.ophtha.2020.07.051 (2021).","journal-title":"Ophthalmology"},{"key":"43420_CR24","doi-asserted-by":"publisher","first-page":"4548","DOI":"10.1167\/iovs.19-27984","volume":"60","author":"K Pappelis","year":"2019","unstructured":"Pappelis, K., Loiselle, A. R., Visser, S. & Jansonius, N. M. Association of systemic medication exposure with glaucoma progression and glaucoma suspect conversion in the groningen longitudinal glaucoma study. Invest. Ophthalmol. Vis. Sci. 60, 4548\u20134555. https:\/\/doi.org\/10.1167\/iovs.19-27984 (2019).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"43420_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.joco.2016.09.009","volume":"29","author":"R Choudhary","year":"2017","unstructured":"Choudhary, R., Kapoor, M. S., Singh, A. & Bodakhe, S. H. Therapeutic targets of renin-angiotensin system in ocular disorders. J. Curr. Ophthalmol. 29, 7\u201316. https:\/\/doi.org\/10.1016\/j.joco.2016.09.009 (2017).","journal-title":"J. Curr. Ophthalmol."},{"key":"43420_CR26","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1136\/bjo.86.6.676","volume":"86","author":"AB Cullinane","year":"2002","unstructured":"Cullinane, A. B., Leung, P. S., Ortego, J., Coca-Prados, M. & Harvey, B. J. Renin-angiotensin system expression and secretory function in cultured human ciliary body non-pigmented epithelium. Br. J. Ophthalmol. 86, 676\u2013683. https:\/\/doi.org\/10.1136\/bjo.86.6.676 (2002).","journal-title":"Br. J. Ophthalmol."},{"key":"43420_CR27","doi-asserted-by":"publisher","first-page":"e0141137","DOI":"10.1371\/journal.pone.0141137","volume":"10","author":"HA Quigley","year":"2015","unstructured":"Quigley, H. A. et al. Losartan treatment protects retinal ganglion cells and alters scleral remodeling in experimental glaucoma. PLoS One 10, e0141137. https:\/\/doi.org\/10.1371\/journal.pone.0141137 (2015).","journal-title":"PLoS One"},{"key":"43420_CR28","doi-asserted-by":"publisher","first-page":"5800","DOI":"10.1167\/iovs.09-3678","volume":"50","author":"H Yang","year":"2009","unstructured":"Yang, H., Hirooka, K., Fukuda, K. & Shiraga, F. Neuroprotective effects of angiotensin II type 1 receptor blocker in a rat model of chronic glaucoma. Invest. Ophthalmol. Vis. Sci. 50, 5800\u20135804. https:\/\/doi.org\/10.1167\/iovs.09-3678 (2009).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"43420_CR29","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.preteyeres.2010.09.002","volume":"30","author":"M Araie","year":"2011","unstructured":"Araie, M. & Mayama, C. Use of calcium channel blockers for glaucoma. Prog. Retin. Eye Res. 30, 54\u201371. https:\/\/doi.org\/10.1016\/j.preteyeres.2010.09.002 (2011).","journal-title":"Prog. Retin. Eye Res."},{"key":"43420_CR30","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0002-9394(88)90179-1","volume":"105","author":"MB Abelson","year":"1988","unstructured":"Abelson, M. B., Gilbert, C. M. & Smith, L. M. Sustained reduction of intraocular pressure in humans with the calcium channel blocker verapamil. Am. J. Ophthalmol. 105, 155\u2013159. https:\/\/doi.org\/10.1016\/0002-9394(88)90179-1 (1988).","journal-title":"Am. J. Ophthalmol."},{"key":"43420_CR31","first-page":"371","volume":"26","author":"K Green","year":"1985","unstructured":"Green, K., Bountra, C., Georgiou, P. & House, C. R. An electrophysiologic study of rabbit ciliary epithelium. Invest. Ophthalmol. Vis. Sci. 26, 371\u2013381 (1985).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"43420_CR32","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1056\/NEJM199911043411907","volume":"341","author":"DR Abernethy","year":"1999","unstructured":"Abernethy, D. R. & Schwartz, J. B. Calcium-antagonist drugs. N. Engl. J. Med. 341, 1447\u20131457. https:\/\/doi.org\/10.1056\/NEJM199911043411907 (1999).","journal-title":"N. Engl. J. Med."},{"key":"43420_CR33","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3109\/02713689609000765","volume":"15","author":"Y Tamaki","year":"1996","unstructured":"Tamaki, Y., Araie, M., Tomita, K. & Tomidokoro, A. Time change of nicardipine effect on choroidal circulation in rabbit eyes. Curr. Eye Res. 15, 543\u2013548. https:\/\/doi.org\/10.3109\/02713689609000765 (1996).","journal-title":"Curr. Eye Res."},{"key":"43420_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2023.05.001","author":"JE Vergroesen","year":"2023","unstructured":"Vergroesen, J. E. et al. Association of systemic medication use with glaucoma and intraocular pressure: The European eye epidemiology consortium. Ophthalmology https:\/\/doi.org\/10.1016\/j.ophtha.2023.05.001 (2023).","journal-title":"Ophthalmology"},{"key":"43420_CR35","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3109\/10641963.2016.1148160","volume":"38","author":"A de la Sierra","year":"2016","unstructured":"de la Sierra, A. et al. Office and ambulatory blood pressure control in hypertensive patients treated with different two-drug and three-drug combinations. Clin. Exp. Hypertens 38, 409\u2013414. https:\/\/doi.org\/10.3109\/10641963.2016.1148160 (2016).","journal-title":"Clin. Exp. Hypertens"},{"key":"43420_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007185.pub2","author":"JM Chen","year":"2010","unstructured":"Chen, J. M., Heran, B. S., Perez, M. I. & Wright, J. M. Blood pressure lowering efficacy of beta-blockers as second-line therapy for primary hypertension. Cochrane Database Syst. Rev. https:\/\/doi.org\/10.1002\/14651858.CD007185.pub2 (2010).","journal-title":"Cochrane Database Syst. Rev."},{"key":"43420_CR37","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1167\/iovs.61.11.25","volume":"61","author":"NG Asefa","year":"2020","unstructured":"Asefa, N. G., Neustaeter, A., Jansonius, N. M. & Snieder, H. Autonomic dysfunction and blood pressure in glaucoma patients: The lifelines cohort study. Invest. Ophthalmol. Vis. Sci. 61, 25. https:\/\/doi.org\/10.1167\/iovs.61.11.25 (2020).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"43420_CR38","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1159\/000335978","volume":"228","author":"Y Okumura","year":"2012","unstructured":"Okumura, Y., Yuki, K. & Tsubota, K. Low diastolic blood pressure is associated with the progression of normal-tension glaucoma. Ophthalmologica 228, 36\u201341. https:\/\/doi.org\/10.1159\/000335978 (2012).","journal-title":"Ophthalmologica"},{"key":"43420_CR39","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.ophtha.2019.03.001","volume":"126","author":"J Kwon","year":"2019","unstructured":"Kwon, J., Jo, Y. H., Jeong, D., Shon, K. & Kook, M. S. Baseline systolic versus diastolic blood pressure dip and subsequent visual field progression in normal-tension glaucoma. Ophthalmology 126, 967\u2013979. https:\/\/doi.org\/10.1016\/j.ophtha.2019.03.001 (2019).","journal-title":"Ophthalmology"},{"key":"43420_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001841.pub2","author":"JM Wright","year":"2009","unstructured":"Wright, J. M. & Musini, V. M. First-line drugs for hypertension. Cochrane Database Syst. Rev. https:\/\/doi.org\/10.1002\/14651858.CD001841.pub2 (2009).","journal-title":"Cochrane Database Syst. Rev."},{"key":"43420_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002003.pub2","author":"CS Wiysonge","year":"2007","unstructured":"Wiysonge, C. S. et al. Beta-blockers for hypertension. Cochrane Database Syst. Rev. https:\/\/doi.org\/10.1002\/14651858.CD002003.pub2 (2007).","journal-title":"Cochrane Database Syst. Rev."},{"key":"43420_CR42","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ajo.2023.03.032","volume":"252","author":"JS Lee","year":"2023","unstructured":"Lee, J. S. et al. Increased risks of open-angle glaucoma in untreated hypertension. Am. J. Ophthalmol. 252, 111\u2013120. https:\/\/doi.org\/10.1016\/j.ajo.2023.03.032 (2023).","journal-title":"Am. J. Ophthalmol."},{"key":"43420_CR43","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/00061198-200408000-00010","volume":"13","author":"P Mitchell","year":"2004","unstructured":"Mitchell, P., Lee, A. J., Rochtchina, E. & Wang, J. J. Open-angle glaucoma and systemic hypertension: The blue mountains eye study. J. Glaucoma 13, 319\u2013326. https:\/\/doi.org\/10.1097\/00061198-200408000-00010 (2004).","journal-title":"J. Glaucoma"},{"key":"43420_CR44","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/00055735-199604000-00016","volume":"7","author":"A Sommer","year":"1996","unstructured":"Sommer, A. Glaucoma risk factors observed in the Baltimore Eye Survey. Curr. Opin. Ophthalmol. 7, 93\u201398. https:\/\/doi.org\/10.1097\/00055735-199604000-00016 (1996).","journal-title":"Curr. Opin. Ophthalmol."},{"key":"43420_CR45","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1161\/CIRCRESAHA.118.312156","volume":"124","author":"MC Acelajado","year":"2019","unstructured":"Acelajado, M. C., Hughes, Z. H., Oparil, S. & Calhoun, D. A. Treatment of resistant and refractory hypertension. Circ. Res. 124, 1061\u20131070. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.312156 (2019).","journal-title":"Circ. Res."},{"key":"43420_CR46","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41433-019-0603-z","volume":"34","author":"A Wu","year":"2020","unstructured":"Wu, A., Khawaja, A. P., Pasquale, L. R. & Stein, J. D. A review of systemic medications that may modulate the risk of glaucoma. Eye (Lond) 34, 12\u201328. https:\/\/doi.org\/10.1038\/s41433-019-0603-z (2020).","journal-title":"Eye (Lond)"},{"key":"43420_CR47","doi-asserted-by":"publisher","first-page":"e0132048","DOI":"10.1371\/journal.pone.0132048","volume":"10","author":"M Kolko","year":"2015","unstructured":"Kolko, M., Horwitz, A., Thygesen, J., Jeppesen, J. & Torp-Pedersen, C. The prevalence and incidence of glaucoma in denmark in a fifteen year period: A nationwide study. PLoS One 10, e0132048. https:\/\/doi.org\/10.1371\/journal.pone.0132048 (2015).","journal-title":"PLoS One"},{"key":"43420_CR48","doi-asserted-by":"publisher","first-page":"e016640","DOI":"10.1136\/bmjopen-2017-016640","volume":"7","author":"SC Seong","year":"2017","unstructured":"Seong, S. C. et al. Cohort profile: The National Health Insurance Service-National Health Screening Cohort (NHIS-HEALS) in Korea. BMJ Open 7, e016640. https:\/\/doi.org\/10.1136\/bmjopen-2017-016640 (2017).","journal-title":"BMJ Open"},{"key":"43420_CR49","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ajo.2020.04.020","volume":"218","author":"TM Kuang","year":"2020","unstructured":"Kuang, T. M., Xirasagar, S., Kao, Y. W., Shia, B. C. & Lin, H. C. Association of systemic hypertension with primary open-angle glaucoma: A population-based case-control study. Am. J. Ophthalmol. 218, 99\u2013104. https:\/\/doi.org\/10.1016\/j.ajo.2020.04.020 (2020).","journal-title":"Am. J. Ophthalmol."},{"key":"43420_CR50","doi-asserted-by":"publisher","unstructured":"Korean Society, H., Hypertension Epidemiology Research Working, G., Kim, H. C. & Cho, M. C. Korea hypertension fact sheet 2018. Clin. Hypertens 24, 13, https:\/\/doi.org\/10.1186\/s40885-018-0098-0 (2018).","DOI":"10.1186\/s40885-018-0098-0"},{"key":"43420_CR51","doi-asserted-by":"publisher","first-page":"d8190","DOI":"10.1136\/bmj.d8190","volume":"344","author":"HK Choi","year":"2012","unstructured":"Choi, H. K., Soriano, L. C., Zhang, Y. & Rodriguez, L. A. Antihypertensive drugs and risk of incident gout among patients with hypertension: Population based case-control study. BMJ 344, d8190. https:\/\/doi.org\/10.1136\/bmj.d8190 (2012).","journal-title":"BMJ"},{"key":"43420_CR52","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1146\/annurev.publhealth.23.100901.140546","volume":"23","author":"T Lumley","year":"2002","unstructured":"Lumley, T., Diehr, P., Emerson, S. & Chen, L. The importance of the normality assumption in large public health data sets. Annu. Rev. Public Health 23, 151\u2013169. https:\/\/doi.org\/10.1146\/annurev.publhealth.23.100901.140546 (2002).","journal-title":"Annu. Rev. Public Health"},{"key":"43420_CR53","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","volume":"117","author":"RB D'Agostino Sr","year":"2008","unstructured":"D\u2019Agostino, R. B. Sr. et al. General cardiovascular risk profile for use in primary care: The Framingham Heart Study. Circulation 117, 743\u2013753. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.699579 (2008).","journal-title":"Circulation"},{"key":"43420_CR54","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.ophtha.2015.11.004","volume":"123","author":"KE Kim","year":"2016","unstructured":"Kim, K. E. et al. Prevalence, awareness, and risk factors of primary open-angle glaucoma: Korea National Health and Nutrition Examination Survey 2008\u20132011. Ophthalmology 123, 532\u2013541. https:\/\/doi.org\/10.1016\/j.ophtha.2015.11.004 (2016).","journal-title":"Ophthalmology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-43420-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-43420-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-43420-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T20:27:15Z","timestamp":1700339235000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-43420-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,27]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["43420"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-43420-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,27]]},"assertion":[{"value":"15 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16224"}}